Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 30184104.
- Also identified by DOI 10.1093/cid/ciy764 and PMC identifier 6399433.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Concentrations of antiretrovirals in hair are associated with virologic outcomes in cohorts of human immunodeficiency virus (HIV)-positive individuals but have never been examined in a clinical trial. We show for the first time the predictive utility of hair antiretroviral concentrations in a large HIV treatment-naive trial (AIDS Clinical Trials Group protocol A5257).
Medical subject headings
- Anti-HIV Agents
- HIV Infections
- HIV-1
- Hair